Related references
Note: Only part of the references are listed.Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy
Hayley C. Affronti et al.
NATURE COMMUNICATIONS (2020)
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma
Laura D. Gamble et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
Naiara Martinez-Velez et al.
NATURE COMMUNICATIONS (2019)
Stalled developmental programs at the root of pediatric brain tumors
Selin Jessa et al.
NATURE GENETICS (2019)
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
Grant L. Lin et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma
Livingstone Fultang et al.
CANCER RESEARCH (2019)
International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma
Maria Tsoli et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma
Diana Carvalho et al.
COMMUNICATIONS BIOLOGY (2019)
The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100
Carmela De Santo et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
Christopher W. Mount et al.
NATURE MEDICINE (2018)
Beyond the Blood: Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma
Katherine Elizabeth Warren
FRONTIERS IN ONCOLOGY (2018)
NANT 2012-01: Phase 1 study of DFMO and celecoxib with cyclophosphamide and topotecan for relapsed or refractory high-risk neuroblastoma.
Araz Marachelian et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets
Tessa B. Johung et al.
CURRENT NEUROPHARMACOLOGY (2017)
Genomic insights into Diffuse intrinsic Pontine Glioma
Danielle H. Lapin et al.
FRONTIERS IN ONCOLOGY (2017)
Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models
Tammy Hennika et al.
PLOS ONE (2017)
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
Alan Mackay et al.
CANCER CELL (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Targeting polyamine metabolism for cancer therapy and prevention
Tracy R. Murray-Stewart et al.
BIOCHEMICAL JOURNAL (2016)
Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1
Matthew Locke et al.
CELL REPORTS (2016)
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
Catherine S. Grasso et al.
NATURE MEDICINE (2015)
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
Giselle L. Saulnier Sholler et al.
PLOS ONE (2015)
Future clinical trials in DIPG: bringing epigenetics to the clinic
Andres Morales La Madrid et al.
FRONTIERS IN ONCOLOGY (2015)
DIPG in children - what can we learn from the past?
Magimairajan Issai Vanan et al.
FRONTIERS IN ONCOLOGY (2015)
Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma
Ann M. Lozier et al.
ONCOTARGET (2015)
Human pontine glioma cells can induce murine tumors
Viola Caretti et al.
ACTA NEUROPATHOLOGICA (2014)
Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling
Altaf Mohammed et al.
CANCER PREVENTION RESEARCH (2014)
Topical combination of diclofenac, calcipotriol, and difluoromethylornithine has beneficial effects comparable to 5-fluorouracil for the treatment of non-melanoma skin cancer in mice
Hans-Christian Pommergaard et al.
JOURNAL OF CHEMOTHERAPY (2014)
AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport
Katherine Samal et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Inhibiting Cycloxygenase and Ornithine Decarboxylase by Diclofenac and Alpha-Difluoromethylornithine Blocks Cutaneous SCCs by Targeting Akt-ERK Axis
Aadithya Arumugam et al.
PLOS ONE (2013)
Diffuse intrinsic pontine gliomas: A systematic update on clinical trials and biology
M. H. A. Jansen et al.
CANCER TREATMENT REVIEWS (2012)
Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
Michelle Monje et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Mammalian Polyamine Metabolism and Function
Anthony E. Pegg
IUBMB LIFE (2009)
Lipophilic Lysine-Spermine Conjugates Are Potent Polyamine Transport Inhibitors for Use in Combination with a Polyamine Biosynthesis Inhibitor
Mark R. Burns et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential
L. M. Shantz et al.
AMINO ACIDS (2007)
Advances toward an understanding of brainstem gliomas
SS Donaldson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Adaptive linear step-up procedures that control the false discovery rate
Yoav Benjamini et al.
BIOMETRIKA (2006)
Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation
JA Nilsson et al.
CANCER CELL (2005)
Prostate intraepithelial neoplasia in Noble rats, a potential intermediate endpoint for chemoprevention studies
KT Christov et al.
EUROPEAN JOURNAL OF CANCER (2004)
A perspective of polyamine metabolism
HM Wallace et al.
BIOCHEMICAL JOURNAL (2003)
Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and grade
TS Weiss et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2002)
A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours
R Paridaens et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
